Insider · CIK 0001685788

MacDougall Ann L.

Reports to the SEC for 2 companies · SANTA MONICA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001685788

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−26.2K sh	$20.00	−$524K	2,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2022-06-14	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	28,179
2022-05-13	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+3,000 sh	$10.93	+$32.8K	26,179
2021-06-15	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	23,179
2021-06-15	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2021-05-13	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−341 sh	$10.00	−$3,410	0
2021-05-13	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+341 sh	$10.00	+$3,410	21,179
2021-03-17	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−6,606 sh	$11.07	−$73.1K	20,838
2021-03-17	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,279 sh	$10.00	+$72.8K	27,444
2021-03-17	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,279 sh	$10.00	−$72.8K	341
2021-03-16	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,949 sh	$11.50	−$22.4K	20,165
2021-03-16	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,231 sh	$10.00	+$22.3K	22,114
2021-03-16	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,231 sh	$10.00	−$22.3K	7,620
2021-03-15	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,483 sh	$10.00	−$64.8K	9,851
2021-03-15	OPIANT PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,600 sh	$11.63	−$65.1K	19,883
2021-03-15	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,483 sh	$10.00	+$64.8K	25,483
2021-02-11	OPIANT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,000 sh	$10.00	+$70K	19,000
2021-02-11	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,000 sh	$10.00	−$70K	16,334
2020-06-19	PROGENICS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2020-06-19	PROGENICS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.1K sh	—	—	0
2020-06-15	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	12,000
2020-06-15	OPIANT PHARMACEUTICALS, INC.Common StockA Award	Director	AAward	+2,500 sh	—	—	2,500
2019-12-13	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2019-12-13	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+36.1K sh	—	—	36,065
2019-12-12	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+5,000 sh	$14.54	+$72.7K	10,000
2019-06-12	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2018-06-13	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	$15.56	+$38.9K	2,500
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+300 sh	$16.78	+$5,034	3,004
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+106 sh	$16.50	+$1,749	106
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+611 sh	$16.75	+$10.2K	717
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.83	+$1,683	817
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+50 sh	$16.28	+$814	867
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+50 sh	$16.00	+$800	917
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+200 sh	$16.25	+$3,250	1,117
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+195 sh	$16.95	+$3,305.25	1,312
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+286 sh	$16.97	+$4,853.42	1,598
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$15.98	+$1,598	1,698
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.29	+$1,629	1,798
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+200 sh	$16.30	+$3,260	1,998
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+6 sh	$16.40	+$98.4	2,004
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+200 sh	$16.84	+$3,368	2,204
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.69	+$1,669	2,304
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.70	+$1,670	2,404
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.64	+$1,664	2,504
2018-06-04	OPIANT PHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+100 sh	$16.67	+$1,667	2,604

Recent filings

Accepted (ET)
Mar 34
MacDougall Ann L.0001385508-23-000061
SEC(opens sec.gov)
Jun 144
MacDougall Ann L.0001385508-22-000084
SEC(opens sec.gov)
May 164
MacDougall Ann L.0001385508-22-000057
SEC(opens sec.gov)
Jun 164
MacDougall Ann L.0001385508-21-000086
SEC(opens sec.gov)
May 134
MacDougall Ann L.0001385508-21-000070
SEC(opens sec.gov)
Mar 174
MacDougall Ann L.0001385508-21-000046
SEC(opens sec.gov)

Companies

Address

C/O OPIANT PHARMACEUTICALS, INC. 401 WILSHIRE BLVD., 12TH FLOOR

SANTA MONICA, CA, 90401